Topic: Teprotumumab for Thyroid-Associated Ophthalmopathy

Educational Objectives: By the end of the activity, participants will be able to:

1. Review current literature in Ophthalmology and related fields to narrow the gap between what is in literature and our daily practice.
2. Change practice patterns that are not consistent with current standards of care.
3. Promote interdisciplinary learning between general Ophthalmologists and appropriate subspecialists (Cornea, Retina, Neuro-Ophthalmology, Oculoplastic, Glaucoma, Pediatrics).

Target Audience: Physician Focus; Ophthalmology physicians and appropriate subspecialists (Cornea, Retina, Neuro-Ophthalmology, Oculoplastic,Glaucoma, Pediatrics)

Planners (varies) : Anthony Liu,MD, General Ophthalmology/Redwood City; Lydia Hsu, MD, Ophthalmology/Redwood City

Speakers: Thomas Hwang, MD, Ophthalmology, Redwood City

CME Staff: Alvin Ting, MD, CME Chief of Education; Julia Carranza, CME Coordinator

Resources:  _{NEJMoa1614949.pdf}

Disclosure: 

The presenters and program planners of this conference have disclosed that he/she has no relevant financial relationships with commercial interest. The CME Department has reviewed their disclosure information for the planner(s) and/or committee / faculty for this program and they do not have relationships that present a conflict of interest.

Accreditation Statement:

Kaiser Permanente Medical Center - Redwood City is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.

Kaiser Permanente Medical Center - Redwood City takes responsibility for the content , quality and scientific integrity of this CME Activity.

Kaiser Permanente does not endorse any brand -name products

Credit Statement:

The Kaiser Permanente Medical Center - Redwood City designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity